UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 476

Sortiert nach

Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3940

Miyachi, Hiroyuki

2023

Link zum Volltext

Verfügbarkeit prüfen

Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors

International journal of molecular sciences, 2021-08, Vol.22 (17), p.9223

Miyachi, Hiroyuki

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands

Journal of pharmacological sciences, 2020-08, Vol.143 (4), p.264-271

2020

Link zum Volltext

Verfügbarkeit prüfen

Crystal Structures of the Human Peroxisome Proliferator-Activated Receptor (PPAR)α Ligand-Binding Domain in Complexes with a Series of Phenylpropanoic Acid Derivatives Generated by a Ligand-Exchange Soaking Method

Biological and Pharmaceutical Bulletin, 2021/09/01, Vol.44(9), pp.1202-1209

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice

Pharmacology, biochemistry and behavior, 2020-04, Vol.191, p.172891, Article 172891

2020

Link zum Volltext

Verfügbarkeit prüfen

核内受容体のノンゲノミックな作用に基づく線維化疾患治療薬創製の試み

YAKUGAKU ZASSHI, 2022/12/01, Vol.142(12), pp.1361-1370

宮地, 弘幸

2022

Link zum Volltext

Verfügbarkeit prüfen

Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands

Bioorganic & medicinal chemistry letters, 2013-03, Vol.23 (6), p.1662-1666

2013

Link zum Volltext

Verfügbarkeit prüfen

Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization

Scientific reports, 2016-03, Vol.6 (1), p.23372, Article 23372

2016

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligands

Current medicinal chemistry, 2007-01, Vol.14 (22), p.2335

Miyachi, Hiroyuki

2007

Link zum Volltext

Verfügbarkeit prüfen

Attempt to Create a Drug for Treatment of Fibrotic Diseases Based on the Non-genomic Action of Nuclear Receptors

YAKUGAKU ZASSHI, 2022/12/01, Vol.142(12), pp.1361-1370

Miyachi, Hiroyuki

2022

Link zum Volltext

Verfügbarkeit prüfen

Structural development of 1H-pyrazolo-[3,4-b]pyridine-4-carboxylic acid derivatives as human peroxisome proliferator-activated receptor alpha (PPARα)-selective agonists

Bioorganic & medicinal chemistry letters, 2019-08, Vol.29 (16), p.2124-2128

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural Basis for PPARα Activation by 1H-pyrazolo-[3,4-b]pyridine Derivatives

Scientific reports, 2020-05, Vol.10 (1), p.7623-7623, Article 7623

2020

Link zum Volltext

Verfügbarkeit prüfen

Hesperetin glucuronides induce adipocyte differentiation via activation and expression of peroxisome proliferator-activated receptor-γ

Bioscience, biotechnology, and biochemistry, 2014, Vol.78 (6), p.1052-1059

2014

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of both enantiomers of 1,2,3,4-tetrahydroisoquinoline derivative IPPAM-1 and enantio-dependency of its positive allosteric modulation of prostacyclin receptor

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2567-2570

2017

Link zum Volltext

Verfügbarkeit prüfen

Structure, solubility, and permeability relationships in a diverse middle molecule library

Bioorganic & medicinal chemistry letters, 2021-04, Vol.37, p.127847-127847, Article 127847

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Transactivation by Hesperetin Glucuronides Is Distinct from That by a Thiazolidine-2,4-dione Agent

Chemical and Pharmaceutical Bulletin, 2014/05/01, Vol.62(5), pp.491-493

2014

Link zum Volltext

Verfügbarkeit prüfen

Structural basis for vitamin D receptor agonism by novel non-secosteroidal ligands

FEBS letters, 2013-04, Vol.587 (7), p.957-963

2013

Link zum Volltext

Verfügbarkeit prüfen

Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesis

Bioorganic & medicinal chemistry, 2005-09, Vol.13 (17), p.5080-5093

2005

Link zum Volltext

Verfügbarkeit prüfen

γ-Mangostin from Garcinia Mangostana Pericarps as a Dual Agonist That Activates Both PPARα and PPARδ

Bioscience, biotechnology, and biochemistry, 2013, Vol.77 (12), p.2430-2435

2013

Link zum Volltext

Verfügbarkeit prüfen

1‐Fluoro‐2,4‐dinitrobenzene and its derivatives act as secretagogues on rodent mast cells

European journal of immunology, 2017-01, Vol.47 (1), p.60-67

2017

Link zum Volltext

Verfügbarkeit prüfen

Challenges Facing Middle Molecule Drug Discovery and How to Overcome Them

Yakugaku zasshi, 2024, Vol.144 (5), p.527-528

2024

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Carbono(di)thioates as Indoleamine 2,3-Dioxygenase 1 Inhibitors

ACS medicinal chemistry letters, 2021-02, Vol.12 (2), p.211-216

2021

Link zum Volltext

Verfügbarkeit prüfen

Structure–anti-MRSA activity relationship of macrocyclic bis(bibenzyl) derivatives

Bioorganic & medicinal chemistry letters, 2013-12, Vol.23 (24), p.6563-6568

2013

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Phthalimide-Based Fluorescent Liver X Receptor Antagonists

Chemical and Pharmaceutical Bulletin, 2010/11/01, Vol.58(11), pp.1525-1528

2010

Link zum Volltext

Verfügbarkeit prüfen

Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures

Acta crystallographica. Section D, Biological crystallography., 2009-08, Vol.65 (8), p.786-795

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(455)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Structural Biology Inspired Development of a Series of Human Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Ligands: From Agonist to Antagonist

Structural Biology-Based Exploration of Subtype-Selective Agonists for Peroxisome Proliferator-Activated Receptors

Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands

Crystal Structures of the Human Peroxisome Proliferator-Activated Receptor (PPAR)α Ligand-Binding Domain in Complexes with a Series of Phenylpropanoic Acid Derivatives Generated by a Ligand-Exchange Soaking Method

Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice

核内受容体のノンゲノミックな作用に基づく線維化疾患治療薬創製の試み

Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands

Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization

Design, synthesis, and structure-activity relationship study of peroxisome proliferator-activated receptor (PPAR) delta-selective ligands

Attempt to Create a Drug for Treatment of Fibrotic Diseases Based on the Non-genomic Action of Nuclear Receptors

Structural development of 1H-pyrazolo-[3,4-b]pyridine-4-carboxylic acid derivatives as human peroxisome proliferator-activated receptor alpha (PPARα)-selective agonists

Structural Basis for PPARα Activation by 1H-pyrazolo-[3,4-b]pyridine Derivatives

Hesperetin glucuronides induce adipocyte differentiation via activation and expression of peroxisome proliferator-activated receptor-γ

Synthesis of both enantiomers of 1,2,3,4-tetrahydroisoquinoline derivative IPPAM-1 and enantio-dependency of its positive allosteric modulation of prostacyclin receptor

Structure, solubility, and permeability relationships in a diverse middle molecule library

Mechanism of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Transactivation by Hesperetin Glucuronides Is Distinct from That by a Thiazolidine-2,4-dione Agent

Structural basis for vitamin D receptor agonism by novel non-secosteroidal ligands

Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesis

γ-Mangostin from Garcinia Mangostana Pericarps as a Dual Agonist That Activates Both PPARα and PPARδ

1‐Fluoro‐2,4‐dinitrobenzene and its derivatives act as secretagogues on rodent mast cells

Challenges Facing Middle Molecule Drug Discovery and How to Overcome Them

Discovery of Carbono(di)thioates as Indoleamine 2,3-Dioxygenase 1 Inhibitors

Structure–anti-MRSA activity relationship of macrocyclic bis(bibenzyl) derivatives

Design and Synthesis of Phthalimide-Based Fluorescent Liver X Receptor Antagonists

Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures

Suchergebnisse filtern